See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Joseph Shaw

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	39719414	0	Shaw JR, Nopp S, Stavik B, et al. Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle. J Am Heart Assoc. 2024 Dec 24:e038782. doi: 10.1161/JAHA.124.038782.
	39442625	0	Anuku D, Carrier M, Le Gal G, et al. Impact of limited language proficiency on participation in venous thromboembolism research: A retrospective analysis. J Thromb Haemost. 2024 Oct 21:S1538-7836(24)00562-2. doi: 10.1016/j.jtha.2024.09.014.
	39362177	0	Shaw JR, Almujalli AA, Xu Y, et al. Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery. Thromb Res. 2024 Nov;243:109172. doi: 10.1016/j.thromres.2024.109172. Epub 2024 Sep 24.
	39029742	0	Levy JH, Shaw JR, Castellucci LA, et al. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2024 Jul 17:S1538-7836(24)00426-4. doi: 10.1016/j.jtha.2024.07.009.
	37949316	0	Shaw JR, Li N, Abdulrehman J, et al. Periprocedural Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer. J Thromb Haemost. 2023 Nov 8:S1538-7836(23)00830-9. doi: 10.1016/j.jtha.2023.10.028.
	37910528	0	Shaw JR, James T, Douxfils J, et al. Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS One. 2023 Nov 1;18(11):e0293632. doi: 10.1371/journal.pone.0293632. eCollection 2023.
	36696204	0	Shaw JR, Castellucci LA, Siegal D, et al. DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature. J Thromb Haemost. 2023 Mar;21(3):433-452. doi: 10.1016/j.jtha.2022.11.029. Epub 2022 Dec 22.
	36696183	0	Aziz J, Wang TF, Siegal D, et al. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. J Thromb Haemost. 2022 Dec 27:S1538-7836(22)18255-3. doi: 10.1016/j.jtha.2022.12.016.
	36200348	0	Shaw JR, Li N, Nixon J, et al. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J Thromb Haemost. 2022 Dec;20(12):2953-2963. doi: 10.1111/jth.15901. Epub 2022 Oct 18.
	35468835	0	Lamb T, Lenet T, Zahrai A, et al. Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis. World J Emerg Surg. 2022 Apr 25;17(1):19. doi: 10.1186/s13017-022-00423-1.
	33065408	0	Shaw JR, Kumar V, Mallick R, et al. Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer. Thromb Res. 2020 Dec;196:437-443. doi: 10.1016/j.thromres.2020.09.035. Epub 2020 Oct 8.
	32969580	0	Kumar V, Shaw JR, Key NS, et al. D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer. Oncologist. 2020 Dec;25(12):1075-1083. doi: 10.1002/onco.13540. Epub 2020 Oct 12.
	32756938	0	Shaw JR, Li N, Vanassche T, et al. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Adv. 2020 Aug 11;4(15):3520-3527. doi: 10.1182/bloodadvances.2020002335.
	32645667	0	Shaw JR, Carrier M, Dowlatshahi D, et al. Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes. Thromb Res. 2020 Nov;195:21-28. doi: 10.1016/j.thromres.2020.06.044. Epub 2020 Jul 1.
	32505262	0	Shaw JR, Kaplovitch E, Douketis J. Periprocedural Management of Oral Anticoagulation. Med Clin North Am. 2020 Jul;104(4):709-726. doi: 10.1016/j.mcna.2020.02.005. Epub 2020 May 12.
	32473692	0	Kaplovitch E, Shaw JR, Douketis J. Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli. Crit Care Clin. 2020 Jul;36(3):465-480. doi: 10.1016/j.ccc.2020.02.004.
	31989095	0	Shaw JR, Zhang T, Le Gal G, et al. Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis. Res Pract Thromb Haemost. 2020 Jan 20;4(1):131-140. doi: 10.1002/rth2.12285. eCollection 2020 Jan.
	31038838	0	Shaw JR, Douketis J, Le Gal G, et al. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. J Thromb Haemost. 2019 Jul;17(7):1171-1178. doi: 10.1111/jth.14468. Epub 2019 May 29.
	30046730	0	Shaw JR, Woodfine JD, Douketis J, et al. Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2018 Feb 16;2(2):282-290. doi: 10.1002/rth2.12076. eCollection 2018 Apr.
	29324333	0	Shaw JR, Castellucci L, Siegal D, et al. Management of direct oral anticoagulant associated bleeding: Results of a multinational survey. Thromb Res. 2018 Mar;163:19-21. doi: 10.1016/j.thromres.2018.01.008. Epub 2018 Jan 5.
	27294776	0	Castellucci LA, Shaw J, Giulivi A, et al. Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study. Thromb Res. 2016 Aug;144:69-71. doi: 10.1016/j.thromres.2016.05.026. Epub 2016 Jun 2.
	26272305	0	Castellucci LA, Shaw J, van der Salm K, et al. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thromb Res. 2015 Oct;136(4):727-31. doi: 10.1016/j.thromres.2015.07.007. Epub 2015 Jul 14.